This 88-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses incorporating artificial intelligence into addiction research workflows, covering practical skills, search optimization, and ethical considerations.

This 60-minute on-demand session from the ASAM 57th Annual Conference addresses bridging science and clinical practice, featuring federal agency research priorities and bidirectional communication strategies for health equity.

In this episode of ASAM Practice Pearls, Dr. Stephen Taylor hosts researchers Dr. Kirsten Smith and Katie Hill to explore the rapidly evolving landscape of kratom and 7-hydroxymitragynine (7-OH). They examine kratom’s complex pharmacology, review current research on kratom and 7-OH, discuss kratom’s addiction potential, withdrawal patterns, and the challenges of kratom in the clinical setting. The episode provides listeners with a basic understanding of kratom and 7-OH products, helping clinicians better understand where to begin when treating patients who use kratom and kratom-derived products.

This one-hour, on-demand, journal article-based activity presents a scoping review on the prevalence of high-potency synthetic opioids (HPSOs) in the nonmedical drug supply and their interactions with medications for opioid use disorder (MOUDs). The interactions between HPSOs and MOUDs are not yet well understood. This review examines the relationship between HPSO exposure and patient outcomes when using common MOUD treatment protocols. It also discusses the implications for clinical practice and suggests directions for future research based on the current research on patient populations impacted by HPSOs.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses pharmacotherapy options for the management of stimulant use disorders.

This 88-hour on-demand conference includes 71 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.